Most parents support childhood vaccines such as MMR and polio, but skepticism about seasonal and newer shots persists, along with distrust of federal agencies.
Merck's CAPVAXIVE could cover approximately 78% of invasive pneumococcal disease cases in youth with chronic health conditions, vs other approved pneumococcal conjugate vaccines.
In its updated guidelines, the AAP recommends that all children aged 6 to 23 months be vaccinated against COVID-19, citing the population's high risk for severe infection.